ABSTRACT Staphylococcus aureus is an early colonizer in the lungs of individuals with cystic fibrosis (CF), but surprisingly, only a limited number of genomes from CFassociated S. aureus isolates have been sequenced. Here, we present the wholegenome sequences of 65 S. aureus isolates obtained from 50 individuals with CF. C ystic fibrosis (CF) is a genetic disease that affects over 70,000 people worldwide. The major cause of death is chronic bacterial lung infections. Early colonization is often with Staphylococcus aureus, and Pseudomonas aeruginosa emerges later as the major cause of mortality. While many researchers focus on P. aeruginosa, the importance of S. aureus in the history of CF lung infections remains understudied (1). Only a small number of whole-genome sequences of CF-associated S. aureus clinical isolates have been reported (1-4). We have started to fill that gap by performing wholegenome sequence analysis of 65 CF-associated S. aureus isolates, obtained mostly from sputum samples, after cultivation on blood agar. This collection is composed of 50 isolates (from 36 individuals) from the Emory Cystic Fibrosis Biospecimen Registry (CFBR) and 15 isolates (from 14 individuals) from Boston Children's Hospital. Metadata associated with the isolates (e.g., methicillin resistance) and the deidentified patient information (e.g., age and sex) were recorded and made available.
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DNA was extracted using the Promega Wizard genomic DNA purification kit, and paired-end libraries were constructed for each isolate using the Nextera XT DNA library kit, with a fragment size of 1,000 bp, and sequenced on an Illumina MiSeq platform using version 3 chemistry. One isolate (CFBR_EB_Sa105, BioSample number SAMN09847825), the first sample of six longitudinal samples from a single patient, also underwent long-read genomic DNA sequencing using the Oxford Nanopore MinION sequencer. DNA was extracted in the same manner as before, and sequencing libraries were prepared using the SQK-RAD003 1D rapid sequencing kit and sequenced on a FLO-MIN106 R9.4 flow cell. The raw Illumina reads for each isolate were processed with the Staphopia analysis pipeline (Docker tag 112017, default parameters) (5) . Staphopia performed sequence quality control by removing Illumina adapters and low-quality bases and reads (Q Ͻ 20). The remaining high-quality reads for each isolate were then subsampled to 100ϫ coverage by Staphopia and assembled using the de novo assembler SPAdes (version 3.11.1, default parameters) (6) . Illumina reads and Nanopore reads for isolate CFBR_EB_Sa105 were assembled using the hybrid assembler Unicycler (version 0.4.0, default parameters) (7). CFBR_EB_Sa105 was sequenced to a total 397ϫ genome coverage (Nanopore, 250ϫ; Illumina, 147ϫ) and assembled into a single 2,782,740-bp-long contig. Genome coverage for the remaining 64 isolates with only Illumina sequencing ranged from 111ϫ to 395ϫ, with an average of 192ϫ coverage, which is sufficient to produce a reliable draft assembly. The N 50 values ranged from 122,702 bp to 806,706 bp, with an average N 50 value of 370,074 bp. The assembled genome sizes ranged from 2,656,854 bp to 2,967,979 bp, with an average size of 2,799,404 bp. The GC contents for these assemblies ranged from 32.59% to 32.85%, with an average GC content of 32.74%. The genome size and GC content values are consistent with what is expected for S. aureus. All assemblies were annotated with the Prokaryotic Genome Annotation Pipeline available from the National Center for Biotechnology Information (NCBI) (8, 9) .
Genome sequence analysis along with the metadata of these S. aureus isolates can be used to understand phenotypic adaptations of this pathogen that are required for survival within the multispecies community of the CF lung.
Data availability. The complete assembly for CFBR_EB_Sa105 and draft assemblies for the remaining samples, as well as the raw Illumina reads, have been deposited in NCBI and are available under BioProject accession number PRJNA480016. Information for each isolate, including accession numbers, is shown in Table 1 .
